Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

Also called NCT04772443

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04772443
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04772443. Randomized; quadruple masking; primary purpose treatment. Start 2021-02 (anticipated); primary completion 2022-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
Condition
Dyslipidemias
Intervention (Drug)
DWJ1506
Intervention (Drug)
DWJ1507
Intervention (Drug)
DWC202011
Intervention (Drug)
DWJ1177
Lead sponsor
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct04772443
Content hash
3a0695cb476509b5d6c81ec9e3e7184d254853ef23e6a34b89cb0a54e214313f